Freshpaint

Founded in 2019 by Michael Malis, San Francisco-based Freshpaint develops a privacy-first data infrastructure platform enabling healthcare organizations to collect, safeguard, and activate customer data while maintaining strict HIPAA compliance. The software-as-a-service platform automatically blocks sensitive patient information by default, preventing data leakage while allowing marketers to safely utilize modern analytics and advertising tools. Operating with a workforce of up to 100 employees, the company provides its compliance and marketing optimization technology to hundreds of healthcare businesses. Freshpaint has raised $41.8 million in total funding, including a $30.7 million Series B round, securing backing from prominent venture firms like Threshold, SignalFire, Intel Capital, Zero Prime, and Y Combinator. This capital supports the ongoing development of advanced features, such as end-to-end patient journey insights and customer acquisition cost metrics, to further optimize healthcare campaigns.

High-Level Overview

Freshpaint is a HIPAA-compliant healthcare data platform designed to help healthcare marketers collect, safeguard, and activate customer data without compromising patient privacy. It replaces unsafe tracking technologies with a Business Associate Agreement (BAA)-supported system that ensures sensitive patient information is never shared with non-compliant third-party tools. This enables healthcare organizations to leverage digital marketing and analytics tools like Google Analytics and Google Ads in a privacy-safe manner, enhancing marketing effectiveness while maintaining strict compliance with healthcare privacy regulations[1][2][3].

For an investment firm, Freshpaint represents a company focused on the healthcare technology sector, specifically privacy-first marketing infrastructure. Its mission is to unlock high-performance marketing for healthcare companies without compromising sensitive data. The company’s investment philosophy likely centers on privacy, compliance, and innovation in healthcare data management. Freshpaint impacts the startup ecosystem by pioneering privacy-first data solutions in a highly regulated industry, addressing a critical gap in healthcare marketing technology[4][5].

For a portfolio company, Freshpaint builds a privacy-first data platform that serves healthcare marketers and organizations needing to comply with HIPAA while collecting and activating customer data. It solves the problem of compliance risk and data leakage inherent in traditional tracking technologies by blocking data sharing with non-compliant tools by default and enabling anonymous visitor identification. Freshpaint has shown strong growth momentum, raising over $30 million in Series B funding in 2023 and rapidly expanding its customer base across healthcare sectors[1][4][7].

---

Origin Story

Freshpaint was founded in 2019 by Michael Malis, initially positioning itself as a general customer data platform (CDP). Early traction came from healthcare clients, which exposed a critical compliance challenge: healthcare marketers wanted to use data freely, but legal and compliance teams were cautious due to HIPAA risks. This led Freshpaint to pivot and specialize in healthcare privacy technology, developing a platform that provides "safety by default" by automatically blocking sensitive health information from flowing to non-compliant third parties unless explicitly allowed[5][7].

The company evolved from a recovering CDP into a dedicated healthcare privacy platform, signing BAAs with healthcare organizations to centralize compliant data collection. This pivot was pivotal, enabling Freshpaint to become a trusted partner for hundreds of healthcare organizations seeking to modernize marketing while safeguarding patient data[1][5].

---

Core Differentiators

• HIPAA Compliance & BAA Support: Freshpaint is built specifically for healthcare, replacing unsafe trackers with a platform that signs Business Associate Agreements, ensuring legal compliance and data protection[1][2].
• Safety-by-Default Architecture: Automatically blocks data sharing with non-HIPAA-compliant tools, reducing human error and compliance risks[5].
• Anonymous Visitor Identification: Enables marketers to track customer journeys without exposing Protected Health Information (PHI)[1][2].
• Server-Side Integrations: Secure connections to analytics and advertising tools like Google Analytics and Google Ads that prevent PHI exposure while maintaining functionality[1][2].
• Ease of Use & Compatibility: Works with existing setups like Google Tag Manager, minimizing implementation effort and cost[2].
• Comprehensive Ecosystem Support: Integrates with analytics, advertising, maps, translation, data warehouses, and video platforms to provide a full marketing stack for healthcare[1].

---

Role in the Broader Tech Landscape

Freshpaint rides the growing trend of privacy-first data management amid increasing regulatory scrutiny in healthcare and digital marketing. The timing is critical as healthcare organizations face mounting pressure to comply with HIPAA and other privacy laws while still leveraging digital marketing to improve patient engagement and outcomes. Market forces such as the FTC’s crackdown on unauthorized data sharing and the need for modern marketing tech stacks favor Freshpaint’s solution[4][5].

By enabling compliant data collection and activation, Freshpaint influences the broader ecosystem by setting new standards for privacy in healthcare marketing technology. It helps healthcare providers, insurers, and retail healthcare companies modernize their marketing infrastructure without risking data breaches, thus fostering trust and innovation in healthcare digital marketing[4].

---

Quick Take & Future Outlook

Freshpaint’s future lies in expanding its reach across the entire healthcare sector, including insurance providers, pharmacies, and retail healthcare, to modernize marketing while safeguarding sensitive data. Trends shaping its journey include increasing regulatory demands, growing digital healthcare adoption, and the rising importance of personalized patient engagement powered by privacy-compliant data.

As Freshpaint continues to invest in technology and talent, it is poised to deepen its influence by enabling smarter, safer healthcare marketing that could improve patient outcomes through timely, personalized communications. Its vision extends beyond compliance to creating a healthier society by leveraging data responsibly, such as automated reminders for screenings and condition-specific care[4].

This positions Freshpaint not just as a compliance tool but as a foundational platform for the future of healthcare marketing, balancing innovation with privacy in a highly sensitive industry.